Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zymeworks (ZYME) EBIT Margin (2021 - 2025)

Zymeworks' EBIT Margin history spans 5 years, with the latest figure at 1755.55% for Q4 2025.

  • On a quarterly basis, EBIT Margin fell 168395.0% to 1755.55% in Q4 2025 year-over-year; TTM through Dec 2025 was 116.65%, a 9409.0% increase, with the full-year FY2025 number at 87.34%, up 9235.0% from a year prior.
  • EBIT Margin hit 1755.55% in Q4 2025 for Zymeworks, down from 88.44% in the prior quarter.
  • Over the last five years, EBIT Margin for ZYME hit a ceiling of 98.28% in Q4 2022 and a floor of 3793.63% in Q1 2022.
  • Historically, EBIT Margin has averaged 765.32% across 5 years, with a median of 443.75% in 2021.
  • Biggest five-year swings in EBIT Margin: soared 371695bps in 2023 and later plummeted -168395bps in 2025.
  • Tracing ZYME's EBIT Margin over 5 years: stood at 510.61% in 2021, then soared by 119bps to 98.28% in 2022, then tumbled by -241bps to 138.37% in 2023, then skyrocketed by 48bps to 71.6% in 2024, then plummeted by -2352bps to 1755.55% in 2025.
  • Business Quant data shows EBIT Margin for ZYME at 1755.55% in Q4 2025, 88.44% in Q3 2025, and 1.38% in Q2 2025.